日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy

pTERT突变状态与接受一线免疫治疗的IV期黑色素瘤患者的生存率相关

Jansen, Philipp; Galetzka, Wolfgang; Thielmann, Carl M; Murali, Rajmohan; Zaremba, Anne; Standl, Fabian; Lodde, Georg; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Stang, Andreas; Griewank, Klaus G

A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities

一部分浆液性输卵管上皮内癌(STIC)样病变与同时发生的高级别子宫内膜癌在基因组上是相关的实体

da Silva, Edaise M; Da Cruz Paula, Arnaud; Dessources, Kimberly; Gordhandas, Sushmita; Selenica, Pier; Abu-Rustum, Nadeem R; Weigelt, Britta; Murali, Rajmohan

Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms.

癌细胞通过不同的机制限制逆转录转座子表达的免疫原性

Sun Siyu, You Eunae, Hong Jungeui, Hoyos David, Del Priore Isabella, Tsanov Kaloyan M, Mattagajasingh Om, Di Gioacchino Andrea, Marhon Sajid A, Chacon-Barahona Jonathan, Li Hao, Jiang Hua, Hozeifi Samira, Rosas-Bringas Omar, Xu Katherine H, Song Yuhui, Lang Evan R, Rojas Alexandra S, Nieman Linda T, Patel Bidish K, Murali Rajmohan, Chanda Pharto, Karacay Ali, Vabret Nicolas, De Carvalho Daniel D, Zenklusen Daniel, LaCava John, Lowe Scott W, Ting David T, Iacobuzio-Donahue Christine A, Solovyov Alexander, Greenbaum Benjamin D

Research autopsy programmes in oncology: shared experience from 14 centres across the world

肿瘤学尸检研究项目:来自全球14个中心的经验分享

Geukens, Tatjana; Maetens, Marion; Hooper, Jody E; Oesterreich, Steffi; Lee, Adrian V; Miller, Lori; Atkinson, Jenny M; Rosenzweig, Margaret; Puhalla, Shannon; Thorne, Heather; Devereux, Lisa; Bowtell, David; Loi, Sherene; Bacon, Eliza R; Ihle, Kena; Song, Mihae; Rodriguez-Rodriguez, Lorna; Welm, Alana L; Gauchay, Lisa; Murali, Rajmohan; Chanda, Pharto; Karacay, Ali; Naceur-Lombardelli, Cristina; Bridger, Hayley; Swanton, Charles; Jamal-Hanjani, Mariam; Kollath, Lori; True, Lawrence; Morrissey, Colm; Chambers, Meagan; Chinnaiyan, Arul M; Wilson, Allecia; Mehra, Rohit; Reichert, Zachery; Carey, Lisa A; Perou, Charles M; Kelly, Erin; Maeda, Daichi; Goto, Akiteru; Kulka, Janina; Székely, Borbála; Szasz, A Marcell; Tőkés, Anna-Mária; Van Den Bogaert, Wouter; Floris, Giuseppe; Desmedt, Christine

Cytologic features of gynecologic germ cell tumors and carcinomas exhibiting germ cell tumor differentiation

妇科生殖细胞肿瘤和癌的细胞学特征,表现出生殖细胞肿瘤分化

Hodgson, Anjelica; Kim, Veronica; Murali, Rajmohan

Cytopathologic features of epithelioid hemangioendothelioma including touch imprints for rapid on-site evaluation

上皮样血管内皮瘤的细胞病理学特征,包括用于快速现场评估的印片法

Lahori, Mega; Dehghani, Amir; Wilson, Christina; Law, Wyanne; Agaram, Narasimhan; Murali, Rajmohan; Sigel, Carlie

Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract

对尿细胞学检查阳性但泌尿系统未发现明显疾病的女性进行评估

Donat, Sherri M; Sonoda, Yukio; Al-Ahmadie, Hikmat; Murali, Rajmohan; Ng, Dianna L; Funt, Samuel A; Park, Kay J

Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status

评估卵巢浆液性交界性肿瘤中嗜酸性细胞以预测BRAF突变状态的观察者间一致性

Chui, M Herman; Murali, Rajmohan; Soslow, Robert A; Matrai, Cathleen; Xing, Deyin; Vang, Russell

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

透明细胞卵巢癌的分子亚型及其对疾病行为和预后的影响

Bolton, Kelly L; Chen, Denise; Corona de la Fuente, Rosario; Fu, Zhuxuan; Murali, Rajmohan; Köbel, Martin; Tazi, Yanis; Cunningham, Julie M; Chan, Irenaeus C C; Wiley, Brian J; Moukarzel, Lea A; Winham, Stacey J; Armasu, Sebastian M; Lester, Jenny; Elishaev, Esther; Laslavic, Angela; Kennedy, Catherine J; Piskorz, Anna; Sekowska, Magdalena; Brand, Alison H; Chiew, Yoke-Eng; Pharoah, Paul; Elias, Kevin M; Drapkin, Ronny; Churchman, Michael; Gourley, Charlie; DeFazio, Anna; Karlan, Beth; Brenton, James D; Weigelt, Britta; Anglesio, Michael S; Huntsman, David; Gayther, Simon; Konner, Jason; Modugno, Francesmary; Lawrenson, Kate; Goode, Ellen L; Papaemmanuil, Elli

TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy

在接受 BRAF 和 MEK 抑制剂治疗的 BRAF 突变型黑色素瘤患者中,TERT 启动子突变与更长的无进展生存期和总生存期相关。

Thielmann, Carl M; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus G